| 49 |
| (3) Diabetes in Primary Care Practice: a case study with coding (Sam) |
| 1. List the components of a diabetes management program. 2. Outline an appropriate treatment plan to establish glycemic control. 3. Develop an effective individualized lifestyle modification to lower cardiometabolic risk. 4. List considerations for adding insulin to an established diabetes treatment regimen. 5. Understand coding for diabetes and related comorbidities. |
| Diabetes guideline and case study with coding. Patient: Sam, 54-year-old African-American male, family history of type 2 diabetes mellitus (T2DM), reports a random glucose reading of 256 mg/dL at a recent health fair, has tried exercise; reports difficulty with compliance, consumes high-fat diet |
| 0.25 |
| Janet Albers, MD; Charles Goldthwaite, PhD Scientific Writer; Lucy Zielinski, Coding Expert; Cynthia Schuch, Graphic Designer, Christine Mueller, MD, CME Committee Reviewer |
| Sponsored by the Illinois Academy of Family Physicians/Family Practice Education Network (IAFP/FPEN) |
| The Illinois Academy of Family Physicians / Family Practice Education Network is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. |
| The Illinois Academy of Family Physicians/Family Practice Education Network designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credit ™. Physicians should claim commensurate with the extent of their February 20, 2009 |
| Merck & Co., Inc., Novo Nordisk, Pfizer. |
| The Illinois Academy of Family Physicians adheres to the conflict of interest policy of the ACCME and the AMA. It is the policy of Illinois AFP to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. All individuals in a position to control the content in our programs are expected to disclose any relationships they may have with commercial companies whose products or services may be mentioned so that participants may evaluate the objectivity of the presentations. In addition, any discussion of off-label, experimental, or investigational use of drugs or devices will be disclosed by the faculty. Only those participants who have no conflict of interest or who agree to an identified resolution process prior to their participation were involved in the CME activity. Speaker Disclosure: Janet Albers, MD disclosed no relevant financial relationship or interest with a proprietary entity producing health care goods or services. Coding Expert Lucy Zielinski has disclosed that she has received a consultant fee for work on this program and is employed by the practice management group Visioneer MD, LLC. CME Committee Reviewer Christine Mueller, MD disclosed no relevant financial relationship or interest with a proprietary entity producing health care goods or services |